Disease / condition

High Utilization / Heavy Use,Psychiatric Hospitalization,Rehospitalization,Intensive Care Psychiatric Disorder,Chronic Psychiatric Disorder,Health Care Utilization clinical trials

Free access to 1 studies·1+ countries·Updated daily
1
Total trials
1+
Countries
1+
Sponsors
N/A
Recruiting
By phase
N/A1
By status
Enrolling by in...1
Top countries
Switzerland1
Top sponsors
Michael Rufer1
Recent trials
Latest clinical trials for High Utilization / Heavy Use,Psychiatric Hospitalization,Rehospitalization,Intensive Care Psychiatric Disorder,Chronic Psychiatric Disorder,Health Care Utilization
NCT06411951Enrolling by...
Integrated Care After Repeated Psychiatric Hospital Stays - Evaluation of an Interdisciplinary Treatment Program
Michael RuferSwitzerland
About this record

Access comprehensive clinical trial information for High Utilization / Heavy Use,Psychiatric Hospitalization,Rehospitalization,Intensive Care Psychiatric Disorder,Chronic Psychiatric Disorder,Health Care Utilization through Pure Global AI's free database. This collection includes 1 clinical trials across multiple phases including N/A.

Research for High Utilization / Heavy Use,Psychiatric Hospitalization,Rehospitalization,Intensive Care Psychiatric Disorder,Chronic Psychiatric Disorder,Health Care Utilization is being conducted in Switzerland and more. Leading sponsors include Michael Rufer. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 1 clinical trials studying High Utilization / Heavy Use,Psychiatric Hospitalization,Rehospitalization,Intensive Care Psychiatric Disorder,Chronic Psychiatric Disorder,Health Care Utilization, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 1+ countries.

Top research sponsors include Michael Rufer, among others.